Want to see IN:BALPHARMA full AI Analyst Report?
Bal Pharma Limited (BALPHARMA) Stock Forecast & Price Target
BALPHARMA Analyst Ratings
There are no analyst ratings in the last 3 months.
BALPHARMA Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | INR 84 | hold | 3.45%Upside | Reiterated | 11/01/26 | ||
| Google General IN | TipRanks - Google | INR 82 | hold | 0.99%Upside | Reiterated | 11/01/26 | ||
| Anthropic General IN | TipRanks - Anthropic | INR 79 | hold | -2.71%Downside | Reiterated | 11/01/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | INR 81 | hold | -0.25%Downside | Reiterated | 11/01/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | INR 82 | hold | 0.99%Upside | Reiterated | 11/01/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | INR 84 | hold | 3.45%Upside | Reiterated | 11/01/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | 11/01/26 | INR 84 | hold | 3.45%Upside | Reiterated | TipRanks - PerPlexity | ||
| Google General IN | 11/01/26 | INR 82 | hold | 0.99%Upside | Reiterated | TipRanks - Google | ||
| Anthropic General IN | 11/01/26 | INR 79 | hold | -2.71%Downside | Reiterated | TipRanks - Anthropic | ||
| OpenAI - Gpt-5.6Sol | 11/01/26 | INR 81 | hold | -0.25%Downside | Reiterated | TipRanks - OpenAI | ||
| DeepSeek - V4Pro | 11/01/26 | INR 82 | hold | 0.99%Upside | Reiterated | TipRanks - DeepSeek | ||
| xAI - Grok-4.3 | 11/01/26 | INR 84 | hold | 3.45%Upside | Reiterated | TipRanks - xAI |
Stocks with the Highest Top Analyst Consensus in the General Sector
BALPHARMA Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, BALPHARMA has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. BALPHARMA average Analyst price target in the past 3 months is ―.
BALPHARMA Financial Forecast
ConsensusINR 0.71
BALPHARMA Earnings Forecast
Next quarter’s earnings estimate for BALPHARMA is INR 0.71 with a range of ― to ―. The previous quarter’s EPS was INR 0.71. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.
ConsensusINR 886M
BALPHARMA Sales Forecast
Next quarter’s sales forecast for BALPHARMA is INR 886.16M with a range of ― to ―. The previous quarter’s sales results were INR 886.16M. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.
BALPHARMA Stock Forecast FAQ
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Bal Pharma Limited?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Bal Pharma Limited?
To buy shares of IN:BALPHARMA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.